Skip to main content
Premium Trial:

Request an Annual Quote

VolitionRx Receives $700K in Funding From Regional Government

NEW YORK (GenomeWeb) — VolitionRx announced today that it has received $700,000 in non-dilutive funding from the government of the Wallonia region of Belgium where the company is headquartered.

According to VolitionRx, roughly $200,000 of the funding is repayable in annual installments over 12 years, beginning in 2020. Additionally, an undisclosed percentage of the company's revenue may be payable to the Walloon regional government over the same period.

VolitionRx said that it intends to use the funds to continue R&D efforts for cancer diagnostics based on its Nucleosomics nucleosome analysis technology.

In late 2017, the firm said that it had received $1.5 million in non-dilutive funding from Sofinex and the Walloon government. It said it has received a total of $3.7 million in non-dilutive funding from local agencies to date.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.